Ambey Laboratories Limited — Others, 26-07-2025: Shareholders meeting

Ambey Laboratories Limited held an Extra-Ordinary General Meeting where shareholders approved key strategic proposals. These included increasing the company's Authorized Share Capital, amending the Articles of Association, and a Preferential Issue of up to 1,08,69,565 Fully Convertible Warrants. These warrants will be issued on a private placement basis to both promoter and non-promoter categories. These resolutions are crucial for capital restructuring and fundraising, enhancing the company's financial flexibility and supporting future growth initiatives. The voting results for these resolutions will be submitted to the stock exchanges shortly.